| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | C-X-C motif chemokine 9|Gamma-interferon-induced monokine|Monokine induced by interferon-gamma|HuMIG, MIG|Small-inducible cytokine B9|CXCL9|CMK|MIG|SCYB9 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human CXCL9 (C-X-C motif chemokine 9) is a molecular target commonly studied in immunology and signal transduction research. Chemokines are small secreted proteins that guide immune-cell trafficking and shape inflammatory microenvironments.
Biological role and mechanism
The biological role of CXCL9 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of CXCL9 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
CXCL9 (C-X-C motif chemokine 9) may also be referenced as C-X-C motif chemokine 9, Gamma-interferon-induced monokine, and Monokine induced by interferon-gamma in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how CXCL9 relates to innate and adaptive immune responses, cytokine signaling networks, host–pathogen interactions, and immune cell activation and trafficking in immunology and signal transduction research.
- Interpreting shifts in CXCL9 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
CXCL9 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with immunology and signal transduction studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell-macrophage crosstalk through reprogramming glutamine metabolism in mice
IF: 15.7 Journal: Nature Communications Author: Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. Cited Date: 2025-10-11
Systemic Inflammation Indices, Chemokines, and Metabolic Markers in Perimenopausal Women
IF: 5 Journal: Nutrients Author: Department of Nursing, Pomeranian Medical University in Szczecin, ?o?nierska 48 St., 71-210 Szczecin, Poland Cited Date: 2025-09-12
LL37‐DNA Complex Drives Vitiligo Progression Through TLR9‐MyD88 Signaling Pathways
IF: 3.9 Journal: Pigment Cell & Melanoma Research Author: Department of Dermatology, Medical Center Hospital of Qionglai City, Qionglai, Sichuan, China. Cited Date: 2024-10-18